Mattel's Investment in Digital Gaming to Create Drag on Full-Year 2026 EPS, UBS Says

MT Newswires Live03-06

Mattel (MAT) remains in the early stages of fully monetizing its intellectual property but its substantial operating expense investment on digital gaming is set to delay near-term EPS growth, UBS said in a Wednesday note.

The company's acquisition of full ownership in mobile games studio Mattel 163 is set to close by the end of Q1, and the integration with its digital games business is expected to create sizeable scale, UBS analysts said. With content licensing and digital games anticipated to be an important driver of margins, Mattel aims to soft-launch two games in H1, the analysts said.

The analysts revised their 2026 EPS estimate Mattel to $1.23 from $1.72, mainly from the operating expense investment of $0.37 in digital gaming, while the 2027 EPS estimate is $1.71, above the consensus of $1.51 and driven by a slightly higher margin.

UBS also forecasts 2026 revenue growth at 4.1%, with 2.8 percentage points from the partial-year contribution of Mattel 163, and 2027 revenue growth at 2.8%, with 90 basis points from the full-year impact of the mobile games studio.

UBS maintained the company's stock rating at buy and reduced the price target to $28 from $30.

Price: 15.85, Change: +0.01, Percent Change: +0.03

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment